What does DR. LAMPAERT - DR. ROMBAUTS do?

DR. LAMPAERT - DR. ROMBAUTS is a specialist medical practice in Damme. Private Limited, started on 27 January 2003, 2 establishments.

What is the address of DR. LAMPAERT - DR. ROMBAUTS?

The registered office of DR. LAMPAERT - DR. ROMBAUTS is located at Leenstraat 15, 8340 Damme.

Is DR. LAMPAERT - DR. ROMBAUTS still active?

Yes. According to the CBE (15 September 2026) DR. LAMPAERT - DR. ROMBAUTS is active, legal situation “Normale toestand”, started on 27 January 2003.

Is DR. LAMPAERT - DR. ROMBAUTS registered on Peppol?

Yes, DR. LAMPAERT - DR. ROMBAUTS is registered on the Peppol network with ID 0208:0479396566.

What is the enterprise number of DR. LAMPAERT - DR. ROMBAUTS?

The enterprise number of DR. LAMPAERT - DR. ROMBAUTS is BE0479396566.

When was DR. LAMPAERT - DR. ROMBAUTS founded?

DR. LAMPAERT - DR. ROMBAUTS was founded on 27 January 2003.

Who are the directors of DR. LAMPAERT - DR. ROMBAUTS?

According to the 2025 annual accounts, the directors of DR. LAMPAERT - DR. ROMBAUTS are: Pascale ROMBAUTS, Philippe LAMPAERT.

Is DR. LAMPAERT - DR. ROMBAUTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 January 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. LAMPAERT - DR. ROMBAUTS make in 2025?

DR. LAMPAERT - DR. ROMBAUTS posted a profit after taxes of € 598,481 in financial year 2025.

What is the revenue of DR. LAMPAERT - DR. ROMBAUTS?

As a small company, DR. LAMPAERT - DR. ROMBAUTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 680,440.

DR. LAMPAERT - DR. ROMBAUTS (Private Limited) - Damme

Dossier DR. LAMPAERT - DR. ROMBAUTS, printed on 15 September 2026 from databakkes.be/en/0479396566/dr-lampaert-dr-rombauts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. LAMPAERT - DR. ROMBAUTS from Damme, company number BE0479396566, closed financial year 2025 with a result of € 598,481 after tax. For that financial year DR. LAMPAERT - DR. ROMBAUTS recorded a gross margin of € 680,440 and equity of € 2.8 million. Compared with financial year 2024, the result moved from € 442,639 to € 598,481. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Growing

€ 2.8 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 598,481

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 91,723

▲ 89% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 332,223 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 71,662

▲ 127% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,895

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 44,413

▼ 26% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 598,529 Gross margin 2022: € 598,529 First fiscal year in the series	€ 642,954 Gross margin 2023: € 642,954 ▲ 7% vs 2022 (€ 598,529) Favourable step	€ 638,086 Gross margin 2024: € 638,086 ▼ 1% vs 2023 (€ 642,954) Unfavourable step	€ 680,440 Gross margin 2025: € 680,440 ▲ 7% vs 2024 (€ 638,086) Favourable step	▲ 7%
Profit after taxes	€ 396,246 Profit after taxes 2022: € 396,246 First fiscal year in the series	€ 443,521 Profit after taxes 2023: € 443,521 ▲ 12% vs 2022 (€ 396,246) Favourable step	€ 442,639 Profit after taxes 2024: € 442,639 Unchanged (€ 443,521) Unfavourable step	€ 598,481 Profit after taxes 2025: € 598,481 ▲ 35% vs 2024 (€ 442,639) Favourable step	▲ 35%
Equity	€ 2,085,071 Equity 2022: € 2,085,071 First fiscal year in the series	€ 2,332,855 Equity 2023: € 2,332,855 ▲ 12% vs 2022 (€ 2,085,071) Favourable step	€ 2,504,227 Equity 2024: € 2,504,227 ▲ 7% vs 2023 (€ 2,332,855) Favourable step	€ 2,770,486 Equity 2025: € 2,770,486 ▲ 11% vs 2024 (€ 2,504,227) Favourable step	▲ 11%
Total debts	€ 99,431 Total debts 2022: € 99,431 First fiscal year in the series	€ 115,968 Total debts 2023: € 115,968 ▲ 17% vs 2022 (€ 99,431) Unfavourable step	€ 293,705 Total debts 2024: € 293,705 ▲ 153% vs 2023 (€ 115,968) Unfavourable step	€ 183,362 Total debts 2025: € 183,362 ▼ 38% vs 2024 (€ 293,705) Favourable step	▼ 38%
Cash	€ 162,372 Cash 2022: € 162,372 First fiscal year in the series	€ 147,356 Cash 2023: € 147,356 ▼ 9% vs 2022 (€ 162,372) Unfavourable step	€ 48,437 Cash 2024: € 48,437 ▼ 67% vs 2023 (€ 147,356) Unfavourable step	€ 91,723 Cash 2025: € 91,723 ▲ 89% vs 2024 (€ 48,437) Favourable step	▲ 89%
Retained profit	€ 2,066,471 Retained profit 2022: € 2,066,471 First fiscal year in the series	€ 2,314,255 Retained profit 2023: € 2,314,255 ▲ 12% vs 2022 (€ 2,066,471) Favourable step	€ 2,485,627 Retained profit 2024: € 2,485,627 ▲ 7% vs 2023 (€ 2,314,255) Favourable step	€ 2,751,886 Retained profit 2025: € 2,751,886 ▲ 11% vs 2024 (€ 2,485,627) Favourable step	▲ 11%
Dividend	€ 211,012 Dividend 2022: € 211,012 First fiscal year in the series	€ 195,737 Dividend 2023: € 195,737 ▼ 7% vs 2022 (€ 211,012) Unchanged	€ 271,267 Dividend 2024: € 271,267 ▲ 39% vs 2023 (€ 195,737) Unchanged	€ 332,223 Dividend 2025: € 332,223 ▲ 22% vs 2024 (€ 271,267) Unchanged	▲ 22%
Balance sheet total	€ 2,184,502 Balance sheet total 2022: € 2,184,502 First fiscal year in the series	€ 2,448,823 Balance sheet total 2023: € 2,448,823 ▲ 12% vs 2022 (€ 2,184,502) Unchanged	€ 2,797,932 Balance sheet total 2024: € 2,797,932 ▲ 14% vs 2023 (€ 2,448,823) Unchanged	€ 2,953,847 Balance sheet total 2025: € 2,953,847 ▲ 6% vs 2024 (€ 2,797,932) Unchanged	▲ 6%

Key figures of DR. LAMPAERT - DR. ROMBAUTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LAMPAERT - DR. ROMBAUTS?

What happened at DR. LAMPAERT - DR. ROMBAUTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 598,481 (▲ 35% vs 2024). Source: NBB ↗
Jan 1, 2018 New establishment in Eeklo. KBO
Jan 1, 2018 New establishment in Roeselare. KBO
Jan 27, 2003 Start of the company according to the CBE. KBO

In short

From € 396,246 profit in 2022 to € 598,481 profit in 2025.

Paid € 806,733 in corporate taxes since 2022.

Best year ever: 2025, with € 598,481 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LAMPAERT - DR. ROMBAUTS? We notify you, reason included.

Follow DR. LAMPAERT - DR. ROMBAUTS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Pascale ROMBAUTS Philippe LAMPAERT

DR. LAMPAERT - DR. ROMBAUTS

Behind DR. LAMPAERT - DR. ROMBAUTS are Pascale ROMBAUTS and Philippe LAMPAERT.

See the full network in the app

Directors

According to the 2025 annual accounts

Pascale ROMBAUTS

Director

Philippe LAMPAERT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Leenstraat 15

8340 Damme

2.302.569.766

Ringlaan 15

9900 Eeklo

Active since 1 January 2018

2.302.569.865

Deltalaan 1

8800 Roeselare